Orally administering parathyroid hormone and calcitonin

Details for Australian Patent Application No. 2002344371 (hide)

Owner Novartis AG

Inventors Ault, Joseph; Bateman, Simon David; McLeod, James F.; Azria, Moise

Agent Davies Collison Cave

Pub. Number AU-B-2002344371

PCT Number PCT/EP02/06017

PCT Pub. Number WO2002/098453

Priority 60/295,169 01.06.01 US

Filing date 31 May 2002

Wipo publication date 16 December 2002

Acceptance publication date 29 June 2006

International Classifications

A61K 38/29 (2006.01) Medicinal preparations containing peptides - Parathyroid hormone (parathormone)

A61K 38/23 (2006.01) Medicinal preparations containing peptides - Calcitonins

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 60/295,169 01.06.01 US

8 May 2003 Application Open to Public Inspection

  Published as AU-B-2002344371

29 June 2006 Application Accepted

  Published as AU-B-2002344371

2 November 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002344372-METHOD AND SYSTEM FOR CONTROLLING BIORESPONSE OF LIVING ORGANISMS

2002344370-NOVEL TARGETS FOR A THERAPEUTIC INTERVENTION IN EBV RELATED DISEASES